153 related articles for article (PubMed ID: 23246221)
1. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.
Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V
Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.
Choi Y; Hur EH; Moon JH; Goo BK; Choi DR; Lee JH
Korean J Intern Med; 2019 Mar; 34(2):390-400. PubMed ID: 29132200
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of let-7a-3 is associated with poor prognosis in myelodysplastic syndrome.
Wu DH; Yao DM; Yang L; Ma JC; Wen XM; Yang J; Guo H; Li XX; Qian W; Lin J; Qian J
Leuk Lymphoma; 2017 Jan; 58(1):96-103. PubMed ID: 27244225
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.
Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z
Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273
[TBL] [Abstract][Full Text] [Related]
5. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes.
Choi JS; Nam MH; Yoon SY; Kang SH
Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751
[TBL] [Abstract][Full Text] [Related]
7. Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes.
Wan C; Wen J; Liang X; Xie Q; Wu W; Wu M; Liu Z
Sci Rep; 2021 Jan; 11(1):183. PubMed ID: 33420276
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes.
Xu F; Zhu Y; He Q; Wu LY; Zhang Z; Shi WH; Liu L; Chang CK; Li X
Sci Rep; 2016 Aug; 6():32232. PubMed ID: 27571714
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome.
Zuo Z; Calin GA; de Paula HM; Medeiros LJ; Fernandez MH; Shimizu M; Garcia-Manero G; Bueso-Ramos CE
Blood; 2011 Jul; 118(2):413-5. PubMed ID: 21602527
[TBL] [Abstract][Full Text] [Related]
10. Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes.
Wan C; Wen J; Huang Y; Li H; Wu W; Xie Q; Liang X; Tang Z; Zhao W; Cheng P; Liu Z
Medicine (Baltimore); 2020 Jul; 99(27):e20904. PubMed ID: 32629683
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.
Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
Int J Clin Exp Pathol; 2015; 8(9):10840-6. PubMed ID: 26617797
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.
Gañán-Gómez I; Wei Y; Yang H; Pierce S; Bueso-Ramos C; Calin G; Boyano-Adánez Mdel C; García-Manero G
PLoS One; 2014; 9(4):e93404. PubMed ID: 24690917
[TBL] [Abstract][Full Text] [Related]
13. [Expression and Function of miR-99a-5p in Bone Marrow of Patients with MDS].
LE Y; Zhang XP; Xiong YQ; Li HY; Zhao WH; Long Y; Luo J; Cheng P; Liu ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):134-140. PubMed ID: 30738460
[TBL] [Abstract][Full Text] [Related]
14. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.
Hofmann WK; de Vos S; Komor M; Hoelzer D; Wachsman W; Koeffler HP
Blood; 2002 Nov; 100(10):3553-60. PubMed ID: 12411319
[TBL] [Abstract][Full Text] [Related]
15. miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation.
Borze I; Scheinin I; Siitonen S; Elonen E; Juvonen E; Knuutila S
Leuk Lymphoma; 2011 Aug; 52(8):1567-73. PubMed ID: 21649547
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression.
Jang SJ; Choi IS; Park G; Moon DS; Choi JS; Nam MH; Yoon SY; Choi CH; Kang SH
Leuk Res; 2016 Aug; 47():172-7. PubMed ID: 27379838
[TBL] [Abstract][Full Text] [Related]
17. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
[TBL] [Abstract][Full Text] [Related]
18. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome.
Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O
Leuk Res; 2010 Mar; 34(3):328-34. PubMed ID: 19615744
[TBL] [Abstract][Full Text] [Related]
19. The effect of miR-223 on cellular behaviour in non-5q myelodysplastic syndromes through targeting RPS14.
Nie Y; Wang S; Yu Y; Zuo X; Xiong B
Pathology; 2020 Aug; 52(5):552-560. PubMed ID: 32571542
[TBL] [Abstract][Full Text] [Related]
20. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.
Li X; Marcondes AM; Gooley TA; Deeg HJ
Blood; 2010 Sep; 116(13):2304-14. PubMed ID: 20562331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
